Avalo Therapeutics, Inc. · NASDAQ:AVTX

Sullivan Christopher Ryan had 138 Avalo Therapeutics, Inc. shares withheld for tax (Form 4)

Traded Jun 10, 2026 · Filed Jun 12, 2026

On Jun 10, 2026, Sullivan Christopher Ryan (Chief Financial Officer) had 138 Avalo Therapeutics, Inc. shares withheld for tax at US$13.10 for US$1,808, leaving 40,773 shares. Filed Jun 12, 2026 (Form 4).

Withheld for tax
138 shares
Price
US$13.10
Value
US$1,808
Holding after
40,773 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 10, 2026Common StockShares withheld for tax138US$13.1040,773Direct

Source

View original at SEC

Related